| Bioactivity | NMDA receptor antagonist 6 (compound 13b) is an antagonist of NMDA receptor, targeting to the glycine binding site. NMDA receptor antagonist 6 shows cytoneuroprotective potency, and protects PC12 cells against NMDA-induced injury and cell apoptosis[1]. |
| Target | NMDA receptor |
| Name | NMDA receptor antagonist 6 |
| Formula | C25H23NO2 |
| Molar Mass | 369.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yang L, et al. Design, synthesis and evaluation of novel 1-phenyl-pyrrolo [1, 2-b] isoquinolin-3-one derivatives as antagonists for the glycine binding site of the NMDA receptor[J]. European Journal of Medicinal Chemistry, 2023: 115624. |
NMDA receptor antagonist 6
CAS: F: C25H23NO2 W: 369.46
NMDA receptor antagonist 6 (compound 13b) is an antagonist of NMDA receptor, targeting to the glycine binding site. NMDA
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.